Werewolf Therapeutics (HOWL) Capital Expenditures (2020 - 2024)

Werewolf Therapeutics has reported Capital Expenditures for 5 years, with the latest figure at $123000.0 in Q4 2024.

• Capital Expenditures for Q4 2024 came in at $123000.0, down 37.88% year-over-year; the trailing twelve-month figure through Sep 2025 was $123000.0 (down 62.61% YoY), and the FY2024 annual result was $254000.0, down 66.97% from the prior year.
• Capital Expenditures climbed to $123000.0 in Q4 2024, from $3000.0 in the prior quarter.
• Over five years, Capital Expenditures peaked at $1.6 million in Q1 2022 and troughed at -$6000.0 in Q2 2021.
• A 5-year average of $292150.0 and a median of $149000.0 in 2021 frame the typical range for Capital Expenditures.
• The widest annual swing landed in 2021, when Capital Expenditures tumbled 113.33%; it then soared 5583.33% in 2022.
• A 5-year view of Capital Expenditures shows it stood at $9000.0 in 2020, then soared by 4600.0% to $423000.0 in 2021, then grew by 22.46% to $518000.0 in 2022, then sank by 61.78% to $198000.0 in 2023, then slumped by 37.88% to $123000.0 in 2024.
• Per Business Quant data, the three most recent Capital Expenditures figures were $123000.0 in Q4 2024, $3000.0 in Q3 2024, and $17000.0 in Q2 2024.